Literature DB >> 28764926

Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters.

Tian-Tian Zhai1, Lisanne V van Dijk2, Bao-Tian Huang3, Zhi-Xiong Lin4, Cássia O Ribeiro2, Charlotte L Brouwer2, Sjoukje F Oosting5, Gyorgy B Halmos6, Max J H Witjes7, Johannes A Langendijk2, Roel J H M Steenbakkers2, Nanna M Sijtsema2.   

Abstract

PURPOSE: To develop and validate prediction models of overall survival (OS) for head and neck cancer (HNC) patients based on image biomarkers (IBMs) of the primary tumor and positive lymph nodes (Ln) in combination with clinical parameters.
MATERIAL AND METHODS: The study cohort was composed of 289 nasopharyngeal cancer (NPC) patients from China and 298 HNC patients from the Netherlands. Multivariable Cox-regression analysis was performed to select clinical parameters from the NPC and HNC datasets, and IBMs from the NPC dataset. Final prediction models were based on both IBMs and clinical parameters.
RESULTS: Multivariable Cox-regression analysis identified three independent IBMs (tumor Volume-density, Run Length Non-uniformity and Ln Major-axis-length). This IBM model showed a concordance(c)-index of 0.72 (95%CI: 0.65-0.79) for the NPC dataset, which performed reasonably with a c-index of 0.67 (95%CI: 0.62-0.72) in the external validation HNC dataset. When IBMs were added in clinical models, the c-index of the NPC and HNC datasets improved to 0.75 (95%CI: 0.68-0.82; p=0.019) and 0.75 (95%CI: 0.70-0.81; p<0.001), respectively.
CONCLUSION: The addition of IBMs from the primary tumor and Ln improved the prognostic performance of the models containing clinical factors only. These combined models may improve pre-treatment individualized prediction of OS for HNC patients.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Head and neck cancer; Image biomarker; Nasopharyngeal cancer; Overall survival; Prediction model

Mesh:

Substances:

Year:  2017        PMID: 28764926     DOI: 10.1016/j.radonc.2017.07.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy.

Authors:  Jia Wu; Micheal F Gensheimer; Nasha Zhang; Fei Han; Rachel Liang; Yushen Qian; Carrie Zhang; Nancy Fischbein; Erqi L Pollom; Beth Beadle; Quynh-Thu Le; Ruijiang Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-03-30       Impact factor: 7.038

2.  Artificial Intelligence and Radiomics in Head and Neck Cancer Care: Opportunities, Mechanics, and Challenges.

Authors:  Lisanne V van Dijk; Clifton D Fuller
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

3.  Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Authors:  Jong Yeob Kim; Andreas Kronbichler; Michael Eisenhut; Sung Hwi Hong; Hans J van der Vliet; Jeonghyun Kang; Jae Il Shin; Gabriele Gamerith
Journal:  Cancers (Basel)       Date:  2019-11-15       Impact factor: 6.639

Review 4.  Prediction of Response in Head and Neck Tumor: Focus on Main Hot Topics in Research.

Authors:  Liliana Belgioia; Silvia Daniela Morbelli; Renzo Corvò
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

5.  Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach.

Authors:  Tang Fh; Chu Cyw; Cheung Eyw
Journal:  BJR Open       Date:  2021-07-05

6.  Extraction parameter optimized radiomics for neoadjuvant chemotherapy response prognosis in advanced nasopharyngeal carcinoma.

Authors:  Yiling Wang; Churong Li; Gang Yin; Jie Wang; Jie Li; Pei Wang; Jie Bian
Journal:  Clin Transl Radiat Oncol       Date:  2021-12-29

7.  Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy.

Authors:  Lisanne V van Dijk; Steven J Frank; Ying Yuan; Brandon Gunn; Amy C Moreno; Abdallah S R Mohamed; Kathryn E Preston; Yun Qing; Michael T Spiotto; William H Morrison; Anna Lee; Jack Phan; Adam S Garden; David I Rosenthal; Johannes A Langendijk; Clifton D Fuller
Journal:  Clin Transl Radiat Oncol       Date:  2021-11-11

Review 8.  The Predictive Value of Tumor Mutation Burden on Clinical Efficacy of Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Meta-Analysis.

Authors:  Biao Ning; Yixin Liu; Miao Wang; Yi Li; Tianzi Xu; Yongchang Wei
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

9.  Frontiers and hotspots of 18F-FDG PET/CT radiomics: A bibliometric analysis of the published literature.

Authors:  Xinghai Liu; Xianwen Hu; Xiao Yu; Pujiao Li; Cheng Gu; Guosheng Liu; Yan Wu; Dandan Li; Pan Wang; Jiong Cai
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

10.  Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases.

Authors:  Marinela Bostan; Georgiana Gabriela Petrică-Matei; Gabriela Ion; Nicoleta Radu; Mirela Mihăilă; Răzvan Hainăroşie; Lorelei Irina Braşoveanu; Viviana Roman; Carolina Constantin; Monica Teodora Neagu
Journal:  Exp Ther Med       Date:  2019-10-25       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.